Cargando…
Rituximab Use in the Management of Childhood Nephrotic Syndrome
Childhood nephrotic syndrome is a challenging and often persistent renal disorder, and its incidence varies between different ethnicities and regions. Corticosteroids have been the main treatment for decades and are effective in most children with idiopathic NS, although 10–15% of these children bec...
Autores principales: | Kallash, Mahmoud, Smoyer, William E., Mahan, John D. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6524616/ https://www.ncbi.nlm.nih.gov/pubmed/31134169 http://dx.doi.org/10.3389/fped.2019.00178 |
Ejemplares similares
-
Clinical presentation and management of nephrotic syndrome in the first year of life: A report from the Pediatric Nephrology Research Consortium
por: Constantinescu, Alexandru R., et al.
Publicado: (2022) -
The Efficacy and Safety of Rituximab for Childhood Steroid-Dependent Nephrotic Syndrome: A Systematic Review and Meta-Analysis
por: Liu, Sidi, et al.
Publicado: (2021) -
Pathophysiology, Evaluation, and Management of Edema in Childhood Nephrotic Syndrome
por: Ellis, Demetrius
Publicado: (2016) -
Hypertension in Childhood Nephrotic Syndrome
por: Shatat, Ibrahim F., et al.
Publicado: (2019) -
Ethnic Differences in Childhood Nephrotic Syndrome
por: Chanchlani, Rahul, et al.
Publicado: (2016)